Smoking‐independent DNA methylation markers for lung cancer risk: External validation in a large population‐based cohort study
Cancer Science · 2025
DOI: 10.1111/cas.16414 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Cancer Science, 2025. Verfasst von Zitong Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. Hauptthemen laut MEDLINE: DNA Methylation, Lung Neoplasms, Smoking, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany), the Federal Ministry of Education and Research (Berlin, Germany), the Baden-Württemberg State Ministry of Science; Research and Arts (Stuttgart, Germany).
Abstract (Originalsprache)
Smoking‐associated epigenetic changes have been linked to lung cancer (LC) risk; however, the role of epigenetic alterations independent of smoking is yet to be fully understood. This study aimed to validate 16 previously reported CpG sites that are independent of smoking yet associated with LC risk within a population‐based prospective cohort. Using the Infinium Methylation EPIC BeadChip kit or the Infinium HumanMethylation450K BeadChip Assay, DNA methylation (DNAm) in whole blood was assessed in four subsets ( n = 736, 1027, 997, and 312) of a population‐based cohort from Germany. The DNAm levels of the 16 smoking‐independent CpG sites were analyzed. Hazard ratios (HRs) and their 95% confidence intervals (95% CIs) were calculated to assess associations of DNAm at the 16 CpG sites with LC risk, adjusting for multiple covariates, including smoking habits and a smoking‐associated DNAm score. Over 17 years of follow‐up, a total of 199 LCs were observed. Among the 16 CpGs, cg02211449 showed a negative association with LC risk (HR [95% CI] per SD increase, = 0.70 [0.63–0.78]), while cg11385536 (1.04 [1.01–1.07]), cg09736286 (1.64 [1.10–2.44]), cg19907023 (1.64 [1.01–2.66]), and cg22032485 (1.52 [1.04–2.21]) displayed positive associations with LC risk. Five of the 16 suggested smoking‐independent CpGs could be externally validated as predictors of LC risk. Further research should address their potential contribution to enhanced LC risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Medical Faculty Heidelberg, University of Heidelberg, Heidelberg, Germany.
- German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
- NCT Heidelberg, National Center for Tumor Diseases (NCT), A partnership between DKFZ and University Hospital, Heidelberg, Germany.
- Division of Preventive Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
ORCID-Profile: Zitong Zhao
Förderung
- The Federal Ministry of Family Affairs, Senior Citizens, Women and Youth (Berlin, Germany)
- the Federal Ministry of Education and Research (Berlin, Germany)
- the Baden-Württemberg State Ministry of Science; Research and Arts (Stuttgart, Germany)
- the Saarland state Ministry for Social Affairs, Health, Women and Family Affairs (Saarbrücken, Germany)
Zitieren
APA
Zhao, Z., Bhardwaj, M., Fan, Z., Li, X., Schrotz-King, P., & Brenner, H. (2025). Smoking‐independent DNA methylation markers for lung cancer risk: External validation in a large population‐based cohort study. Cancer Science. https://doi.org/10.1111/cas.16414
Vancouver
Zhao Z, Bhardwaj M, Fan Z, Li X, Schrotz-King P, Brenner H. Smoking‐independent DNA methylation markers for lung cancer risk: External validation in a large population‐based cohort study. Cancer Science. 2025. doi:10.1111/cas.16414
BibTeX
@article{Zhao2025,
author = {Zhao, Zitong and Bhardwaj, Megha and Fan, Ziwen and Li, Xianzhe and Schrotz-King, Petra and Brenner, Hermann},
title = {Smoking‐independent DNA methylation markers for lung cancer risk: External validation in a large population‐based cohort study},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.16414}
}
EUVIMED